All Stories

  1. PD model using Zebra Fish
  2. What is next in African neuroscience?
  3. Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
  4. Alzheimer’s Disease: An Update and Insights Into Pathophysiology
  5. The effect of clopidogrel and aspirin on the severity of traumatic brain injury in a rat model
  6. Correction to: Elevation of Pro‑inflammatory and Anti‑inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury
  7. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis
  8. Atypical Antipsychotic Lumateperone Effects on the Adrenal Gland With Possible Beneficial Effect of Quercetin Co-administration
  9. The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
  10. Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks
  11. Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
  12. Integrated neural technologies: Solutions beyond tomorrow
  13. Editorial: Contribution of Translational Animal Models to the Systems Biology of Neurodegenerative Disorders
  14. Editorial: Biomarkers in Neurology
  15. Animal Model for Leigh Syndrome
  16. FOXRED1 silencing in mice: a possible animal model for Leigh syndrome
  17. siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice
  18. Corrigendum to: Genetic underpinnings in Alzheimer’s disease – a review
  19. Light-Emitting Diode (LED) Therapy Attenuates Neurotoxicity of Methanol-Induced Memory Impairment and Apoptosis in The Hippocampus
  20. Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)
  21. Tubulin and Tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
  22. C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
  23. Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls
  24. Genetic underpinnings in Alzheimer’s disease – a review
  25. Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model
  26. Thyroxine (T4) Transfer from Blood to Cerebrospinal Fluid in Sheep Isolated Perfused Choroid Plexus: Role of Multidrug Resistance-Associated Proteins and Organic Anion Transporting Polypeptides
  27. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease
  28. Interactions between cannabis and schizophrenia in humans and rodents
  29. Tau protein as a biomarker for asphyxia: A possible forensic tool?
  30. Familiarity, perception, and reasons for electronic-cigarette experimentation among the general public in Malaysia: Preliminary insight
  31. Developmental neurotoxic effects of Malathion on 3D neurosphere system
  32. Developing expertise in bioinformatics for biomedical research in Africa
  33. Widening participation would be key in enhancing bioinformatics and genomics research in Africa
  34. Neurogenomics: An Egyptian perspective
  35. NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies
  36. Applied and translational neurogenomics
  37. Investigation of redox status in chronic cerebral hypoperfusion-induced neurodegeneration in rats
  38. The Protective Effect of Calcitriol on Diabetic Neuropathy in STZ-induced Diabetic Rats
  39. Possible alteration of catecholaminergic transporters in specific brain areas of iron deficit rats
  40. Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity
  41. Prevalence of depression in schizophrenic patients evaluated by the Calgary Depression Scale in Shebin El-Kom, Menoufiya
  42. Early iron deficiency and attentional deficits from basic science to treatment
  43. 445 – Effects of early iron deficiency on catecholaminergic transporters in rat brain
  44. MDMA: Interactions with other psychoactive drugs
  45. Methylphenidate improves cognitive deficits produced by infantile iron deficiency in rats
  46. Effect of some calcium channel blockers in experimentally induced diabetic nephropathy in rats
  47. Interactions between 3,4-Methylenedioxymethamphetamine and Ethanol in Humans and Rodents
  48. EFFECT OF SOME CALCIUM CHANNELS BLOCKERS IN EXPERIMENTALLY INDUCED DIABETIC NEPHROPATHY IN RATS
  49. RENOPROTECTIVE EFFECT OF ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN DIABETIC HYPERTENSIVE NEPHROPATHY IN RATS
  50. The mechanism of action of calcium channel blockers in the treatment of diabetic nephropathy
  51. The role of calcium channel blockers in the treatment of diabetic nephropathy